CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Current assets:
Cash and cash equivalents	$ 140,231	$ 120,614	[1]
Trade accounts receivable, net of allowances of $5,161 and $6,194	120,741	118,145	[1]
Inventories, net	230,455	206,919	[1]
Deferred tax assets	44,276	48,616	[1]
Prepaid expenses and other current assets	26,886	26,858	[1]
Total current assets	562,589	521,152	[1]
Property, plant and equipment, net	203,882	200,310	[1]
Intangible assets, net	413,906	197,163	[1]
Goodwill	349,574	249,764	[1]
Deferred tax assets	6,259	15,412	[1]
Other assets	9,524	8,338	[1]
Total assets	1,545,734	1,192,139	[1]
Current liabilities:
Accounts payable, trade	45,935	50,752	[1]
Deferred revenue	5,183	4,197	[1]
Accrued compensation	36,957	28,079	[1]
Accrued expenses and other current liabilities	40,173	36,354	[1]
Debt, Current	1,875	0	[1]
Total current liabilities	130,123	119,382	[1]
Long-term borrowings under senior credit facility	410,000	186,875	[1]
Long-term convertible securities	211,095	205,182	[1]
Deferred tax liabilities	76,782	2,083	[1]
Other liabilities	31,756	12,527	[1]
Total liabilities	859,756	526,049	[1]
Commitments and contingencies			[1]
Stockholders’ equity:
Preferred stock; no par value; 15,000 authorized shares; none outstanding	0	0	[1]
Common stock; $0.01 par value; 60,000 authorized shares; 41,453 and 41,042 issued at September 30, 2014 and December 31, 2013, respectively	415	410	[1]
Additional paid-in capital	769,208	750,918	[1]
Treasury stock, at cost; 8,903 shares at September 30, 2014 and December 31, 2013	(367,121)	(367,121)	[1]
Accumulated other comprehensive income (loss)	(14,318)	927	[1]
Retained earnings	297,794	280,956	[1]
Total stockholders’ equity	685,978	666,090	[1]
Total liabilities and stockholders’ equity	$ 1,545,734	$ 1,192,139	[1]

[1] See Note 1 of these condensed consolidated financial statements for discussion of the impact of the change in accounting for the medical device excise tax.